LYLA MASTERS: Open Payments
NPI 1225327323 · KANSAS CITY, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$6,182 in 239 payments from 26 companies in 2025. Trend: 2023 $4,253 · 2024 $4,465 · 2025 $6,182
Food & beverage: $4,305Consulting: $1,740Education: $136
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 15 | $2,107 |
| Amgen Inc. | 55 | $723 |
| ABBVIE INC. | 41 | $455 |
| PFIZER INC. | 17 | $395 |
| UCB, Inc. | 16 | $374 |
| AstraZeneca Pharmaceuticals LP | 10 | $290 |
| E.R. Squibb & Sons, L.L.C. | 12 | $239 |
| ANI Pharmaceuticals, Inc. | 12 | $230 |
| Novartis Pharmaceuticals Corporation | 9 | $205 |
| GENZYME CORPORATION | 3 | $205 |
Products named: TREMFYA, OTEZLA, XELJANZ, Bimzelx, SAPHNELO, KRYSTEXXA, RINVOQ, ORENCIA.
Industry payments across MO — which companies pay providers there.
